in € million |
|
Share capital |
|
Share premium |
|
Treasury shares (incl. forward contracts) |
|
Other reserves |
|
Retained earnings |
|
Shareholders’ equity |
|
Non-controlling interests |
|
Total Equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance at January 1, 2024 |
|
3 |
|
11,731 |
|
(44) |
|
474 |
|
10,744 |
|
22,908 |
|
162 |
|
23,070 |
Net profit for the period |
|
– |
|
– |
|
– |
|
– |
|
250 |
|
250 |
|
30 |
|
280 |
Other comprehensive income |
|
– |
|
– |
|
– |
|
161 |
|
7 |
|
168 |
|
5 |
|
173 |
Total comprehensive income |
|
– |
|
– |
|
– |
|
161 |
|
257 |
|
418 |
|
35 |
|
453 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend |
|
– |
|
(414) |
|
– |
|
– |
|
(246) |
|
(660) |
|
(7) |
|
(667) |
Stock options/share units granted |
|
– |
|
– |
|
– |
|
31 |
|
– |
|
31 |
|
– |
|
31 |
Stock options/share units vested/canceled |
|
– |
|
– |
|
– |
|
(26) |
|
26 |
|
– |
|
– |
|
– |
Reissued shares |
|
– |
|
– |
|
54 |
|
– |
|
(33) |
|
21 |
|
– |
|
21 |
Repurchase of shares |
|
– |
|
– |
|
(52) |
|
– |
|
– |
|
(52) |
|
– |
|
(52) |
Forward contracts to repurchase shares |
|
– |
|
– |
|
(105) |
|
– |
|
– |
|
(105) |
|
– |
|
(105) |
Expenditures issuance new shares |
|
– |
|
(4) |
|
– |
|
– |
|
– |
|
(4) |
|
– |
|
(4) |
Divestment/deconsolidation of subsidiary with NCI |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
(17) |
|
(17) |
Remuneration of hybrid bonds (equity) |
|
– |
|
– |
|
– |
|
– |
|
(28) |
|
(28) |
|
– |
|
(28) |
Transfer |
|
– |
|
– |
|
– |
|
70 |
|
(89) |
|
(19) |
|
19 |
|
– |
Other changes |
|
– |
|
– |
|
– |
|
– |
|
1 |
|
1 |
|
(6) |
|
(5) |
Balance at December 31, 2024 |
|
3 |
|
11,313 |
|
(147) |
|
710 |
|
10,632 |
|
22,511 |
|
186 |
|
22,697 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net profit (loss) for the period |
|
– |
|
– |
|
– |
|
– |
|
(1,081) |
|
(1,081) |
|
42 |
|
(1,039) |
Other comprehensive income |
|
– |
|
– |
|
– |
|
(610) |
|
69 |
|
(541) |
|
(8) |
|
(549) |
Total comprehensive income |
|
– |
|
– |
|
– |
|
(610) |
|
(1,012) |
|
(1,622) |
|
34 |
|
(1,588) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend |
|
– |
|
(379) |
|
– |
|
– |
|
(280) |
|
(659) |
|
(59) |
|
(718) |
Stock options and share units granted |
|
– |
|
– |
|
– |
|
38 |
|
– |
|
38 |
|
– |
|
38 |
Stock options and share units vested/canceled |
|
– |
|
– |
|
– |
|
(19) |
|
19 |
|
– |
|
– |
|
– |
Reissued shares |
|
– |
|
– |
|
19 |
|
– |
|
(14) |
|
5 |
|
– |
|
5 |
Repurchase own shares covering SBC plans |
|
– |
|
– |
|
(80) |
|
– |
|
– |
|
(80) |
|
– |
|
(80) |
Repurchase own shares for cancellation purposes |
|
– |
|
– |
|
(1,000) |
|
– |
|
4 |
|
(996) |
|
– |
|
(996) |
Acquisition of NCI without a change in control |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
(101) |
|
(101) |
Remuneration and redemption of hybrid bonds (equity) |
|
– |
|
– |
|
– |
|
– |
|
(776) |
|
(776) |
|
– |
|
(776) |
Transfer |
|
– |
|
– |
|
– |
|
(10) |
|
(109) |
|
(119) |
|
119 |
|
– |
Other changes |
|
– |
|
– |
|
– |
|
– |
|
(58) |
|
(58) |
|
– |
|
(58) |
Balance at December 31, 2025 |
|
3 |
|
10,934 |
|
(1,208) |
|
109 |
|
8,406 |
|
18,244 |
|
179 |
|
18,423 |
See also Note 16 Equity.